A Comparative Study of Sensorineural Hearing Loss in the Treatment of Nasopharyngeal Carcinoma: Conventional Radiation Vs IMRT Technique

Authors

  • Pitchayaponne Klunklin Department of Radiology, Faculty of Medicine, Chiang Mai University
  • Suwicha Isaradisaikul Department of Otolaryngology, Faculty of Medicine, Chiang Mai University
  • Patrinee Traisathit Department of Statistics, Faculty of Science, Chiang Mai University
  • Imjai Chitapanarux Department of Radiology, Faculty of Medicine, Chiang Mai University

Abstract

Purpose: This prospective study compares the incidence and severity of sensorineural hearing loss (SNHL) in the nasopharyngeal carcinoma patients who received treatment by conventional two-dimensional (2D) radiation to IMRT technique. Methods and materials: Between November 2009 and August 2010, 18 nasopharyngeal carcinoma patients were treated with chemoradiation (similar to the Intergroup 0099 trial) and randomly assigned to receive radiotherapy by conventional radiation (n=10) and IMRT technique (n=8). Pure-tone audiometries were performed before treatment and on the day that completed radiation to evaluate hearing threshold at low speech (frequencies pure tone average; conversation in normal activities) and high speech frequency (4 kHz). An increase in bone conduction threshold more than 15 dB from baseline was considered as signifi cant SNHL. Results: The incidences of SNHL at PTA were 10% and 12.5% (p=0.608) and at 4 kHz were 15% and 56.2% (p=0.014) for conventional radiation and IMRT group, respectively. There was no difference in the severities of SNHL between two groups at both PTA and 4 kHz (p>0.05). Conclusion: No signifi cant difference was seen in the incidence of SNHL at PTA between conventional radiation and IMRT technique. The incidence of SNHL at 4 kHz were signifi cant greater in IMRT group. The severity of SNHL was also not different between two radiation techniques.

References

Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310–1317.

Butler EB, The BS, Grant, WH, et al. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radia Oncol Biol Phys 1999;45:21-32.

Eisbruch A, Ship JA, Martel MK, et al. Parotid gland sparing in patients undergoing bilateral head and neck irradiation; techniques and early results. Int J Radiat Oncol Biol Phys 1996;36:469-480.

Eisbruch A, Ten Haken RK, Kim HM, et al. Dose, volume, and function relationships in parotid salivary glands following conformal, and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;45:577-587.

Low WK, Toh ST, Wee J, Fook-Chong SM and De Yun Wang. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: A single, blinded, randomized Study. JCO 2006;24:1904-1909.

Pan CC, Eisbruch A, Lee JS, et al. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 2005;61:1393–1402.

Herrmann F, Dörr W, Müller R, et al. A prospective study on radiation-induced changes in hearing function. Int J Radiat Oncol Biol Phys 2006;65:1338–1344.

Schot LJ, Hilgers FJ, Keus RB, Schouwenburg PF, Dreschler WA. Late effects of radiotherapy on hearing. Eur Arch Otorhinolaryngol 1992;249(6):305–8.

Oh YT, Kim CH, Choi JH, et al. Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma. Radiother Oncol 2004;72:79–82.

Raaijmakers E, Engelen AM. Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature. Radiother Oncol 2002;65:1–7.

Zuur CL, Simis YJ, Lansdaal PE, et al. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: A multivariate analysis. Int J Radiat Oncol Biol Phys 2007;68:1320–1325.

Zurr CL, Simis YJ, Coen RR, et al. Hearing loss in IMRT for head-and-neck tumors. Int J Radiation Oncol Biol Phys 2009;74:490–496.

Honore HB, Bentzen SM, Möller K, et al. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: Individualized risk estimation. Radiother Oncol 2002;65:9–16.

Kwong DLW, Wei W, Sham J, et al. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: A prospective study of the effect of radiation and cisplatin treatment. Int J Radiat Oncol Biol Phys 1996;36:281–289.

Chan SH, Ng WT, Kam KL, Lee MC, Choi CW, Yau TK, et al. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: A longitudinal analysis. Int J Radiat Oncol Biol Phys 2009;73:1335–1342.

Wang LF, Kuo WR, Ho KY, et al. A long-term study on hearing status in patients with nasopharyngeal carcinoma after radiotherapy. Otol & Neurotol 2004;25:168–173.

Low WK, Burgess R, Fong KW, Wang DY. Effect of radiotherapy on retro-cochlear auditory pathways. Laryngoscope 2005;115:1823-1826.

Herrmann F, Dörr W, Müller R, et al. A prospective study on radiation-induced changes in hearing function. Int J Radiat Oncol Biol Phys 2006;65:1338–1344.

Ho WK, Wei WI, Kwong DL, et al. Long-term sensorineural hearing defi cit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study. Head Neck1999;21:547-53.

Varghese G, Sahota JS, Hazarika P, et al. Hearing anomalies following radiation therapy for head and neck cancers. Indian J Exp Biol 1996;34:878–879.

Ho WK, Wei WI, Kwong DL, et al. Long-term sensorineural hearing defi cit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study. Head Neck1999;21:547-53.

Chen WC, Jackson A, Budnick AS, Pfi ster DG, Kraus DH, Hunt MA, et al. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer 2006 Feb 15;106:820-829.

Ondrey FG, Greig JR, Herscher L. Radiation dose to otologic structures during head and neck cancer radiation therapy. Laryngoscope. 2000;110:217–221.

Lee NY. A phase II multi-institutional study of IMRT ± chemotherapy for nasopharyngeal carcinoma (RTOG 0225): Preliminary results. Int J Radiat Oncol Biol Phys 2006;64:57–62.

Downloads

Published

2012-06-29

How to Cite

1.
Klunklin P, Isaradisaikul S, Traisathit P, Chitapanarux I. A Comparative Study of Sensorineural Hearing Loss in the Treatment of Nasopharyngeal Carcinoma: Conventional Radiation Vs IMRT Technique. J Thai Assn of Radiat Oncol [Internet]. 2012 Jun. 29 [cited 2024 Nov. 15];18(1):10-7. Available from: https://he01.tci-thaijo.org/index.php/jtaro/article/view/203459

Issue

Section

Original articles